Surface receptors delivering opposite signals regulate the function of human NK cells

Seminars in Immunology

Volumn 12, Issue 2, 2000, Pages 129-138

  Moretta, Alessandro ^a   Biassoni, Roberto ^b   Bottino, Crittina ^b   Moretta, Lorenzo ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Activating receptors; HLA class I; Inhibitory receptors; Natural cytotoxicity; NK cells

Indexed keywords

CELL RECEPTOR; CELL SURFACE RECEPTOR; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN;

CELL ACTIVATION; CELL MEDIATED CYTOTOXICITY; CHEMICAL STRUCTURE; CYTOLYSIS; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR CLONING; NATURAL KILLER CELL; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

EID: 0034128023     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.2000.0215     Document Type: Article

References (71)

1. Moretta A, Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC, Moretta L. Receptors for HLA-class I-molecules in human natural killer cells. Annu Rev Immunol. 14:1996;619-648.
2. Lanier LL. NK cell receptors. Annu Rev Immunol. 16:1998;359-393.
3. Karre K. An unexpected petition for pardon. Curr Biol. 2:1992;613-616.
4. Moretta A, Bottino C, Pende D, Tripodi G, Tambussi G, Viale O, Orengo A, Barbaresi M, Merli A, Ciccone E, Moretta L. Identification of four subsets of human CD3-CD16+ NK cells by the expression of clonally distributed functional surface molecules. Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med. 172:1990;1589-1598.
5. Moretta A, Vitale M, Bottino C, Orengo, AM, Morell L, Augugliaro R, Barbaresi M, Ciccone E, Moretta L. P58 molecules as putative receptors for MHC class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med. 178:1993;597-604.
6. Litwin V, Gumperz JE, Parham P, Phillips JH, Lanier LL. NKB 1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J Exp Med. 180:1994;537-543.
7. Vitale M, Sivori S, Pende D, Augugliaro R, Di Donato C, Amoroso A, Malnati M, Bottino C, Moretta L, Moretta A. Physical and functional independency of p70 and p58 cell receptors for HLA-class I. Their role in the definition of different groups of alloreactive NK cell clones. Proc Natl Acad Sci USA. 93:1996;1453-1457.
8. Döhring C, Scheidegger D, Samaridis J, Cella M, Colonna M. A human killer inhibitory receptor specific for HLA-A. J Immunol. 156:1996;3098-3101.
9. Pende D, Biassoni R, Cantoni C, Verdiani S, Falco M, Di Donato C, Accame L, Bottino C, Moretta A, Moretta L. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140 kDa disulfide-linked dimer. J Exp Med. 184:1996;505-518.
10. Colonna M, Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science. 268:1995;405-408.
11. Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati MS, Vitale M, B ottino C, Moretta L, Moretta A, Long EO. Molecular clones of the p58 NK cell receptor reveal immunoglobulin related molecules with diversity in both the extra- and intracellular domains. Immunity. 2:1995;439-449.
12. D'Andrea A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, Lanier LL. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. J Immunol. 155:1995;2306-2310.
13. Moretta A, Vitale M, Sivori S, Bottino C, Morelli L, Augugliaro R, Bar baresi M, Pende D, Ciccone E, López-Botet M, Moretta L. Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J Exp Med. 180:1994;545-555.
14. Carretero M, Cantoni C, Bellón T, Bottino C, Biassoni R, Rodrí guez A, Pérez-Villar JJ, Moretta L, Moretta A, López-Botet M. The CD94 and NKG2A C-type lectins covalently assemble to form a NK cell inhibitory receptor for HLA-class I molecules. Eur J Immunol. 27:1997;563-567.
15. Phillips JH, Chang C, Mattson J, Gumperz JE, Parham P, Lanier LL. CD94 and a novel associated protein (94AP) form an NK cell receptor involved in the recognition of HLA-A, -B, -C allotypes. Immunity. 5:1996;163-172.
16. Houchins JP, Yabe T, McSherry C, Bach FH. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med. 173:1991;1017-1020.
17. Sivori S, Vitale M, Bottino C, Marcenaro E, Sanseverino L, Parolini S, Moretta L, Moretta A. CD94 functions as a natural killer cell inhibitory receptor for different HLA-class-I alleles. Identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur J Immunol. 26:1996;2487-2492.
18. Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH. Human n atural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol. 157:1996;4741-4745.
19. Braud VM, Yvonne Jones E, McMichael A. The human major; histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol. 27:1997;1164-1169.
20. Braud VM, Allan DSJ, O'Callaghan CA, Soderstrom K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 391:1998;795-799.
21. Lee N, Llano M, Carretero M, Ishitani A, Navarro F, López-Botet M, Gherarty D. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA. 95:1998;5199-5204.
22. Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med. 187:1998;813-818.
23. Colonna M, Navarro F, Bellón T, Llano M, Pilar G, Samaridis J, Angman L, Cella M, López-Botet M. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med. 186:1997;1809-1818.
24. Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, Hsu ML. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity. 7:1997;273-282.
25. +natural killer cell clones. Int Immunol. 11:1999;29-35.
26. Navarro F, Llano M, Bellon T, Colonna M, Geraghty D E, López-Botet M. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-Gl and HLA-E molecules co-expressed on target cells. Eur J Immunol. 29: 1999;277-283.
27. Cantoni C, Verdiani S, Falco M, Pessino A, Cilli M, Conte R, Pende D, Ponte M, Mikaelsson MS, Moretta L, and Biassoni R. p49, a novel putative HLA-class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. Eur J Immunol. 28:1998;1980-1990.
28. Rajagopalan S, Long EO. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med. 189:1999;1093-1100.
29. Ponte M, Cantoni C, Biassoni R, Tradori-Cappai A, Bentivoglio G, Vital e C, Bertone S, Moretta A, Moretta L, Mingari MC. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci USA. 96:1999;5674-5679.
30. Long EO. Regulation of immune responses through inhibitory recep tors. Annu Rev Immunol. 17:1998;875-904.
31. Falco M, Biassoni R, Bottino C, Vitale M, Sivori S, Augugliaro R, Moret ta L, Moretta A. Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells. J Exp Med. 190:1999;793-807.
32. Cantoni C, Bottino C, Augugliaro R, Morelli L, Marcenaro E, Castriconi R, Vitale M, Pende D, Sivori S, Millo R, Biassoni R, Moretta L. Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur J Immunol. 29:1999;3148-3158.
33. Lanier LL, Corliss B, Phillips JH. Arousal and inhibition of huma n NK cells. Immunol Rev. 155:1997;145-154.
34. Lanier LL, Ruitenberg JJ, Phillips JH. Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes. J Immunol. 141:1988;3478-3485.
35. Moretta A, Tambussi G, Ciccone E, Pende D, Melioli G, Moretta L. CD16 Surface molecules regulate the cytolytic function of CD3-CD16+ human 'natural killer' cells. Int J Cancer. 44:1989;727-730.
36. Moretta A, Poggi A, Pende D, Tripodi G, Orengo AM, Pella N, Augugliaro R, Bottino C, Ciccone E, Moretta L. CD69-mediated pathway of lymphocyte activation. Anti-CD69 mAbs trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing TCR α/β J Exp Med. 174:1991;1393-1398.
37. Shibuya A, Campbell D, Hannum C, Ylssel H, Franz-Bacon K, McClanahan T, Kitamura T, Nicholl J, Sutherland GR, Lanier LL, Phillips JH. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity. 4:1996;573-581.
38. Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, Bottino C, Moretta L. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med. 182:1995;875-884.
39. Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale M, Conte R, Poggi A, Moretta A, Moretta L. The human leukocyte antigen (HLA)-C-specific 'activatory' or 'inhibitory' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med. 183:1996;645-650.
40. Bottino C, Sivori S, Vitale M, Cantoni C, Falco M, Pende D, Morelli L, Augugliaro R, Semenzato GP, Biassoni R, Moretta L, Moretta A. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur J Immunol. 26:1996;1816-1824.
41. Olcese L, Cambiaggi A, Semenzato G, Bottino C, Moretta A, Vivier E. Human killer cell activatory receptors for MHC class I molecules are included in a multimetric complex expressed by natural killer cells. J Immunol. 158: 1997;5083-5085.
42. Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH. Immunorecepto r DAP12 bearing a tyrosine-based activation motifs is involved in activating NK cells. Nature. 39:1998;703-707.
43. Cantoni C, Biassoni R, Pende D, Sivori S, Accame L, Moretta L, Moretta A, Bottino C. The activating form of CD94 receptor complex. The CD94-associated Kp39 protein represents the product of the NKG2-C gene. Eur J Immunol. 28:1998;327-338.
44. Lanier LL, Corliss B, Wu J, Phillips JH. Association of DAP12 with the activating CD94/NKG2C NK cell receptors. Immunity. 8:1998;693-701.
45. Biassoni R, Pessino A, Malaspina A, Cantoni C, Sivori S, Moretta L, Moretta A. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur J Immunol. 27:1997;3095-3099.
46. Moretta A, Biassoni R, Bottino C, Pende D, Vitale M, Poggi A, Mingari MC, Moretta L. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev. 155:1997;105-117.
47. Sivori S, Pende D, Bottino C, Marcenaro E, Pessino A, Biassoni R, Moretta L, Moretta A. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human natural killer cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur J Immunol. 29:1999;1656-1666.
48. Moretta A, Biassoni R, Bottino C, Mingari MC, Moretta L. The 'nat ural cytotoxicity receptors' which trigger human NK-mediated cytolysis. Immunol Today, 1999.
49. Garrido F, Ruiz-Cabello F, Cabrera T, Pérez-Villar JJ, López-Botet M, Duggan-Keen M, Stern PL. Implications for immunosurveillance of altered HLA-class I phenotypes in human tumours. Immunol Today. 18:1997;89-95.
50. Sivori S, Vitale M, Morelli L, Sanseverino L, Augugliaro R, Bottino C, Moretta L, Moretta A. p46, a novel natural killer cell-specific surface molecule which mediates cell activation. J Exp Med. 186:1997;1129-1136.
51. Pessino A, Sivori S, Bottino C, Malaspina A, Morelli L, Moretta L, Biassoni R, Moretta A. Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med. 188:1998;953-960.
52. Biassoni R, Pessino A, Bottino C, Pende D, Moretta L, Moretta A. The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity. Eur J Immunol. 29:1999;1014-1020.
53. Gumperz JE, Parham P. The enigma of the natural killer cell. Nature. 378:1995;245-248.
54. Pende D, Parolini S, Pessino A, Sivori S, Augugliaro R, Morelli L, Marc enaro E, Accame L, Malaspina A, Biassoni R, Bottino C, Moretta L, Moretta A. Identification and molecular characterization of NKp30, a novel trigge ring receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med. 190:1999;1505-1516.
55. Falco M, Cantoni C, Bottino C, Moretta A, Biassoni R. Identificat ion of the rat homologue of the human NKp46 triggering receptor. Immunol Lett. 68:1999;411-414.
56. Trinchieri G. Biology of natural killer cells. Adv Immunol. 47:1989;187-376.
57. Ferrini S, Miescher S, Zocchi MR, von Fliedner V, Moretta A. Phenotypic and functional characterization of recombinant interleukin-2 (rIL-2)-induced killer cells: analysis at the population and clonal level. J Immunol. 138:1987;1297-1302.
58. Vitale M, Bottino C, Sivori S, Sanseverino L, Castriconi R, Marcenaro R, Augugliaro R, Moretta L, Moretta A. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells is involved in non-MHC restricted tumor cell lysis. J Exp Med. 187:1998;2065-2072.
59. Cebriàn M, Yague E, Rincòn M, Lòpez-Botet M, De Landàzuri MO, Sànchez-Madrid F. Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J Exp Med. 168:1988;1621-1637.
60. Hemler ME. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol. 8:1990;365-400.
61. Cantoni C, Bottino C, Vitale M, Pessino A, Augugliaro R, Malaspina A, Parolini S, Moretta L, Moretta A, and Biassoni R. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med. 189:1999;787-795.
62. Wu J, Song Y, Bakker A BH, Bauer A, Spies T, Lanier L L, Phillips, J H. An activating immunoreceptor complex formed by NKG2D and DAP10. Science. 285: 1999;730-732.
63. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 285:1999;727-729.
64. Mingari MC, Vitale C, Cambiaggi A, Schiavetti F, Melioli G, Ferrini S, Poggi A. Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int Immunol. 7:1995;697-703.
65. Ferrini S, Cambiaggi A, Meazza R, Sforzini S, Marciano S, Mingari MC, Moretta L. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur J Immunol. 24:1994;2294-2298.
66. Phillips JH, Gumperz JE, Parham P, Lanier LL. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptor on T lymphocytes. Science. 128:1995;403-405.
67. +T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci USA. 93:1996;12433-12438.
68. +T cells. Proc Natl Acad Sci USA. 95:1998;1172-1177.
69. Mingari MC, Moretta A, Moretta L. Regulation of KIR expression i n human T cells: a safety mechanism that may impair protective T-cell responses. Immunol Today. 19:1998;153-157.
70. Poggi A, Pella N, Morelli L, Spada F, Revello V, Sivori S, Augugliaro R, Moretta L, Moretta A. p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans. Eur J Immunol. 25:1995;369-376.
71. Meyaard L, Adema GJ, Chang C, Woollatt E, Sutherland GR, Lanier LL, Phillips JH. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity. 7:1997;283-290.